Cargando…
Gut microbiota in patients with obesity and metabolic disorders — a systematic review
BACKGROUND: Previous observational studies have demonstrated inconsistent and inconclusive results of changes in the intestinal microbiota in patients with obesity and metabolic disorders. We performed a systematic review to explore evidence for this association across different geography and popula...
Autores principales: | XU, Zhilu, JIANG, Wei, HUANG, Wenli, LIN, Yu, CHAN, Francis K.L., NG, Siew C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903526/ https://www.ncbi.nlm.nih.gov/pubmed/35093025 http://dx.doi.org/10.1186/s12263-021-00703-6 |
Ejemplares similares
-
Reply
por: Xu, Zhilu, et al.
Publicado: (2021) -
Multi-omic analyses identify mucosa bacteria and fecal metabolites associated with weight loss after fecal microbiota transplantation
por: Zhang, Fen, et al.
Publicado: (2022) -
Gut Microbiota and Metabolic Disorders
por: Hur, Kyu Yeon, et al.
Publicado: (2015) -
Gut microbiota‐derived synbiotic formula (SIM01) as a novel adjuvant therapy for COVID‐19: An open‐label pilot study
por: Zhang, Lin, et al.
Publicado: (2022) -
Gut and obesity/metabolic disease: Focus on microbiota metabolites
por: Lin, Ke, et al.
Publicado: (2022)